Tag Archive | "strategy"

DSM offers innovative technology, collaborative partnerships

Tags: ,


Written and published by partneringNEWS.

At BIO-Europe Spring®, DSM Biologics and DSM BioSolutions are interested in partnering their proprietary technology packages as well as their CMO services. “Clients can access DSM’s technology either as a CMO client or by out-licensing the technology to optimize biopharma manufacturing, and so reduce costs and risks,” Karen King, president of DSM Biologics, a business unit of DSM Pharmaceutical Products (DPP), pointed out. Read the full story

Aptalis Pharmaceutical Technologies: New formulations drive value

Tags: ,


Written and published by partneringNEWS.

By controlling the taste, bioavailability or timed release of drugs, Aptalis Pharmaceutical Technologies can help drug developers recoup the USD 30 billion lost to the industry each year because of patients not refilling—or never filling—their prescriptions. Controlling these factors also may improve compliance, lower dosage amounts, reduce side effects and improve efficacy as well as extend product life and, in some cases, expand the market for a given drug. Read the full story

Innovative deals drive J&J’s strategy

Tags: , , ,


Written and published by partneringNEWS.

During the past 18 months, J&J has melded its many pharmaceutical companies into one entity, known as Janssen, the Pharmaceutical Companies of Johnson & Johnson. Now the various companies can align goals and strategies, allowing Janssen to speak with one voice, according to Robert J. Willsvice president of alliance management, pharmaceuticals group.  Read the full story

Alexza to explore strategic options

Tags: ,


Written by Soham Chatterjee for Reuters.

Alexza Pharmaceuticals Inc said it will explore options including sale of assets, strategic business combination, or partnerships.  Read the full story

Pfizer outlines its supply strategy

Tags: , , , ,


By Patricia Van Arnum.

John Kelly, Vice President of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.  Read the full story

Blog matters: Technology & IP strategy – block, run, team up or all 3?

Tags: , , ,


Source: Duncan Bucknell, IP Thinktank

The June 2007 edition of LESI's les Nouvelles carried an interesting article by Dr Adrian Carter from Boehringer Ingelheim on co-promotion and co-marketing partnerships in the pharmaceutical industry. Read the full story